Advertisement
AMN vs USPH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMN is a StrongBuy and USPH is a Hold.
Aroon Indicator for AMN shows an upward move is likely
AMN's Aroon Indicator triggered a bullish signal on October 22, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 162 similar instances where the Aroon Indicator showed a similar pattern. In 133 of the 162 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 24, 2026. You may want to consider a long position or call options on AMN as a result. In 61 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
AMN moved above its 50-day moving average on September 24, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AMN crossed bullishly above the 50-day moving average on September 17, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.
Following a +12.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMN advanced for three days, in 222 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
AMN broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. AMN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.247) is normal, around the industry mean (204.132). P/E Ratio (15.812) is within average values for comparable stocks, (18.957). Projected Growth (PEG Ratio) (1.159) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.100) among similar stocks. P/S Ratio (0.397) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
USPH in downward trend: price may drop because broke its higher Bollinger Band on October 22, 2026
USPH broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 35 similar instances where the stock broke above the upper band. In 26 of the 35 cases the stock fell afterwards. This puts the odds of success at 74%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for USPH moved out of overbought territory on October 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 27 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where USPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on USPH as a result. In 55 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for USPH just turned positive on October 22, 2026. Looking at past instances where USPH's MACD turned positive, the stock continued to rise in 28 of 42 cases over the following month. The odds of a continued upward trend are 67%.
Following a +2.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where USPH advanced for three days, in 217 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Aroon Indicator entered an Uptrend today. In 159 of 254 cases where USPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. USPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.870) is normal, around the industry mean (204.132). USPH's P/E Ratio (507.529) is considerably higher than the industry average of (18.957). Projected Growth (PEG Ratio) (2.823) is also within normal values, averaging (2.498). Dividend Yield (0.021) settles around the average of (0.100) among similar stocks. P/S Ratio (1.556) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. USPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
AMN | USPH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 46 | 89 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 73 Overvalued | 97 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 54 | 90 | |
PRICE GROWTH RATING 1..100 | 34 | 42 | |
P/E GROWTH RATING 1..100 | 17 | 1 | |
SEASONALITY SCORE 1..100 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMN's Valuation (73) in the Personnel Services industry is in the same range as USPH (97) in the Medical Or Nursing Services industry. This means that AMN’s stock grew similarly to USPH’s over the last 12 months.
AMN's Profit vs Risk Rating (100) in the Personnel Services industry is in the same range as USPH (100) in the Medical Or Nursing Services industry. This means that AMN’s stock grew similarly to USPH’s over the last 12 months.
AMN's SMR Rating (54) in the Personnel Services industry is somewhat better than the same rating for USPH (90) in the Medical Or Nursing Services industry. This means that AMN’s stock grew somewhat faster than USPH’s over the last 12 months.
AMN's Price Growth Rating (34) in the Personnel Services industry is in the same range as USPH (42) in the Medical Or Nursing Services industry. This means that AMN’s stock grew similarly to USPH’s over the last 12 months.
USPH's P/E Growth Rating (1) in the Medical Or Nursing Services industry is in the same range as AMN (17) in the Personnel Services industry. This means that USPH’s stock grew similarly to AMN’s over the last 12 months.
| AMN | USPH | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 88% | 1 day ago 71% |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 72% |
| Momentum ODDS (%) | 1 day ago 66% | 1 day ago 71% |
| MACD ODDS (%) | N/A | 1 day ago 67% |
| TrendWeek ODDS (%) | 1 day ago 71% | 1 day ago 68% |
| TrendMonth ODDS (%) | 1 day ago 74% | 1 day ago 68% |
| Advances ODDS (%) | 1 day ago 74% | 11 days ago 66% |
| Declines ODDS (%) | 15 days ago 79% | 4 days ago 67% |
| BollingerBands ODDS (%) | 1 day ago 80% | 1 day ago 74% |
| Aroon ODDS (%) | 1 day ago 82% | 1 day ago 63% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMN’s FA Score shows that 1 FA rating(s) are green while USPH’s FA Score has 1 green FA rating(s).
- AMN’s FA Score: 1 green, 4 red.
- USPH’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMN’s TA Score shows that 5 TA indicator(s) are bullish while USPH’s TA Score has 4 bullish TA indicator(s).
- AMN’s TA Score: 5 bullish, 4 bearish.
- USPH’s TA Score: 4 bullish, 4 bearish.
Price Growth
AMN (@Hospital/Nursing Management) experienced а +17.05% price change this week, while USPH (@Hospital/Nursing Management) price change was +3.20% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +1.24%. For the same industry, the average monthly price growth was -2.96%, and the average quarterly price growth was +22.44%.
Reported Earning Dates
AMN is expected to report earnings on Nov 05, 2026.
USPH is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Hospital/Nursing Management (+1.24% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement